Fig. 2From: Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patientsiNKT cell expression of CD62L in control, moderate and severe CFS/ME patients at 0 and 6 months. iNKT cells expressing CD62L as a percentage of total iNKT cells. Data is presented as mean ± SEM where statistical significance was accepted as p < 0.05. CFS/ME Chronic Fatigue Syndrome/Myalgic Encephalomyelitis, SEM standard error of the meanBack to article page